662 related articles for article (PubMed ID: 15524399)
41. A comparative study of Cutibacterium (Propionibacterium) acnes clones from acne patients and healthy controls.
Lomholt HB; Scholz CFP; Brüggemann H; Tettelin H; Kilian M
Anaerobe; 2017 Oct; 47():57-63. PubMed ID: 28434779
[TBL] [Abstract][Full Text] [Related]
42. In vivo porphyrin production by P. acnes in untreated acne patients and its modulation by acne treatment.
Borelli C; Merk K; Schaller M; Jacob K; Vogeser M; Weindl G; Berger U; Plewig G
Acta Derm Venereol; 2006; 86(4):316-9. PubMed ID: 16874416
[TBL] [Abstract][Full Text] [Related]
43. Correlation between Propionibacterium acnes biotypes, lipase activity and rash degree in acne patients.
Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
J Dermatol; 2000 Aug; 27(8):519-22. PubMed ID: 10989576
[TBL] [Abstract][Full Text] [Related]
44. The facial red fluorescence of ultraviolet photography: is this color due to Propionibacterium acnes or the unknown content of secreted sebum?
Youn SW; Kim JH; Lee JE; Kim SO; Park KC
Skin Res Technol; 2009 May; 15(2):230-6. PubMed ID: 19622132
[TBL] [Abstract][Full Text] [Related]
45. Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant.
Bellew S; Thiboutot D; Del Rosso JQ
J Drugs Dermatol; 2011 Jun; 10(6):582-5. PubMed ID: 21637898
[TBL] [Abstract][Full Text] [Related]
46. Investigation of the mechanism of action of nonablative pulsed-dye laser therapy in photorejuvenation and inflammatory acne vulgaris.
Seaton ED; Mouser PE; Charakida A; Alam S; Seldon PM; Chu AC
Br J Dermatol; 2006 Oct; 155(4):748-55. PubMed ID: 16965424
[TBL] [Abstract][Full Text] [Related]
47. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes).
Gloor M; Lamerz A; Franke-Hoffman M
Zentralbl Bakteriol A; 1981 Feb; 248(4):502-8. PubMed ID: 6452774
[TBL] [Abstract][Full Text] [Related]
48. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity.
Jasson F; Nagy I; Knol AC; Zuliani T; Khammari A; Dréno B
Exp Dermatol; 2013 Sep; 22(9):587-92. PubMed ID: 23947673
[TBL] [Abstract][Full Text] [Related]
49. Decrease in Diversity of Propionibacterium acnes Phylotypes in Patients with Severe Acne on the Back.
Dagnelie MA; Corvec S; Saint-Jean M; Bourdès V; Nguyen JM; Khammari A; Dréno B
Acta Derm Venereol; 2018 Feb; 98(2):262-267. PubMed ID: 29136261
[TBL] [Abstract][Full Text] [Related]
50. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates.
Dréno B; Pécastaings S; Corvec S; Veraldi S; Khammari A; Roques C
J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():5-14. PubMed ID: 29894579
[TBL] [Abstract][Full Text] [Related]
51. Incidence and lipolytic activity of Propionibacterium acnes (Corynebacterium acnes group I) and P. granulosum (C. acnes group II) in acne and in normal skin.
Whiteside JA; Voss JG
J Invest Dermatol; 1973 Feb; 60(2):94-7. PubMed ID: 4266325
[No Abstract] [Full Text] [Related]
52. Acne: inflammation.
Farrar MD; Ingham E
Clin Dermatol; 2004; 22(5):380-4. PubMed ID: 15556722
[TBL] [Abstract][Full Text] [Related]
53. A microbial aetiology of acne: what is the evidence?
Shaheen B; Gonzalez M
Br J Dermatol; 2011 Sep; 165(3):474-85. PubMed ID: 21495996
[TBL] [Abstract][Full Text] [Related]
54. Propionibacterium acnes: an update on its role in the pathogenesis of acne.
Beylot C; Auffret N; Poli F; Claudel JP; Leccia MT; Del Giudice P; Dreno B
J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):271-8. PubMed ID: 23905540
[TBL] [Abstract][Full Text] [Related]
55. Effects of Propionibacterium acnes on various mRNA expression levels in normal human epidermal keratinocytes in vitro.
Akaza N; Akamatsu H; Kishi M; Mizutani H; Ishii I; Nakata S; Matsunaga K
J Dermatol; 2009 Apr; 36(4):213-23. PubMed ID: 19348660
[TBL] [Abstract][Full Text] [Related]
56. [Cytotoxicity in acne vulgaris].
Vignale RA; Espasandín J; Lasalvia E; Borras A
Med Cutan Ibero Lat Am; 1982; 10(1):31-6. PubMed ID: 6214674
[TBL] [Abstract][Full Text] [Related]
57. Propionibacterium acnes strain populations in the human skin microbiome associated with acne.
Fitz-Gibbon S; Tomida S; Chiu BH; Nguyen L; Du C; Liu M; Elashoff D; Erfe MC; Loncaric A; Kim J; Modlin RL; Miller JF; Sodergren E; Craft N; Weinstock GM; Li H
J Invest Dermatol; 2013 Sep; 133(9):2152-60. PubMed ID: 23337890
[TBL] [Abstract][Full Text] [Related]
58. Effects of topical erythromycin on aerobic and anaerobic surface flora.
Bernstein JE; Shalita AR
Acta Derm Venereol; 1980; 60(6):537-9. PubMed ID: 6162344
[TBL] [Abstract][Full Text] [Related]
59. Intergeneric and intrageneric inhibition between strains of Propionibacterium acnes and micrococcaceae, particularly Staphylococcus epidermidis, isolated from normal skin and acne lesions.
Holland KT; Cunliffe WJ; Eady EA
J Med Microbiol; 1979 Feb; 12(1):71-82. PubMed ID: 34728
[TBL] [Abstract][Full Text] [Related]
60. Sampling and detection of skin Propionibacterium acnes: current status.
Alexeyev OA; Jahns AC
Anaerobe; 2012 Oct; 18(5):479-83. PubMed ID: 22877737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
